<SEC-DOCUMENT>0000902664-21-004649.txt : 20211028
<SEC-HEADER>0000902664-21-004649.hdr.sgml : 20211028
<ACCEPTANCE-DATETIME>20211028203951
ACCESSION NUMBER:		0000902664-21-004649
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20211028
FILED AS OF DATE:		20211028
DATE AS OF CHANGE:		20211028

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Matrix Capital Management Company, LP
		CENTRAL INDEX KEY:			0001410830
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40971
		FILM NUMBER:		211360169

	BUSINESS ADDRESS:	
		STREET 1:		1000 WINTER STREET
		STREET 2:		C/O MATRIX CAPITAL MANAGEMENT
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		781-522-4948

	MAIL ADDRESS:	
		STREET 1:		1000 WINTER STREET
		STREET 2:		C/O MATRIX CAPITAL MANAGEMENT
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

	FORMER NAME:	
		FORMER CONFORMED NAME:	Matrix Capital Management Company, LLC
		DATE OF NAME CHANGE:	20070827

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GOEL DAVID E.
		CENTRAL INDEX KEY:			0001548144

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40971
		FILM NUMBER:		211360168

	MAIL ADDRESS:	
		STREET 1:		C/O MATRIX CAPITAL MANAGEMENT CO., LP
		STREET 2:		1000 WINTER STREET, SUITE 4500
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aura Biosciences, Inc.
		CENTRAL INDEX KEY:			0001501796
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				320271970
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		85 BOLTON STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140
		BUSINESS PHONE:		(617)500-8864

	MAIL ADDRESS:	
		STREET 1:		85 BOLTON STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2021-10-28</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001501796</issuerCik>
        <issuerName>Aura Biosciences, Inc.</issuerName>
        <issuerTradingSymbol>AURA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001410830</rptOwnerCik>
            <rptOwnerName>Matrix Capital Management Company, LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1000 WINTER STREET</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>WALTHAM</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02451</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001548144</rptOwnerCik>
            <rptOwnerName>GOEL DAVID E.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O MATRIX CAPITAL MANAGEMENT CO., LP</rptOwnerStreet1>
            <rptOwnerStreet2>1000 WINTER STREET, SUITE 4500</rptOwnerStreet2>
            <rptOwnerCity>WALTHAM</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02451</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Series E Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, par value $0.00001 per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>2327870</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnotes</value>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The Series E Convertible Preferred Stock is convertible at any time, at the holder's election, and has no expiration date. The shares of Series E Convertible Preferred Stock will automatically convert into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.</footnote>
        <footnote id="F2">The securities reported herein are held by Matrix Capital Management Master Fund, LP (the &quot;Matrix Fund&quot;). Matrix Capital Management Company, LP (the &quot;Investment Manager&quot;), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (&quot;Mr. Goel&quot;, and together with the Investment Manager, the &quot;Reporting Persons&quot;), serves as the Managing General Partner of the Investment Manager.</footnote>
        <footnote id="F3">The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Matrix Capital Management Company, LP, by: /s/ David E. Goel, its Managing General Partner</signatureName>
        <signatureDate>2021-10-28</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ David E. Goel</signatureName>
        <signatureDate>2021-10-28</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
